Child-Pugh Score 15 (Class C): Diagnostic Criteria & Management

Detailed clinical evaluation, scoring breakdown, and evidence-based guidance for an exact Child-Pugh score of 15 (Child-Pugh Class C).

A Child-Pugh score of 15 places the patient into Child-Pugh Class C. Severe decompensated cirrhosis and end-stage liver disease. High risk of immediate multi-organ complications and mortality. Derived from the five validated parameters of the child pugh score calculator—total serum bilirubin, serum albumin, international normalized ratio (INR) or prothrombin time prolongation, ascites severity, and hepatic encephalopathy grade—an exact score of 15 serves as an essential clinical indicator for hepatologists, gastroenterologists, and surgeons evaluating liver reserve, surgical risk, and medication dosing safety.

Diagnostic Breakdown and Parameter Permutations for Score 15

On the 5-to-15 point child-turcotte-pugh classification scale, an exact score of 15 can arise from specific mathematical permutations across the five diagnostic criteria. Each variable contributes 1, 2, or 3 points based on established clinical cutoffs:

1. Total Bilirubin: <2.0 mg/dL (<34 µmol/L in standard cirrhosis or <4.0 mg/dL in cholestatic PBC/PSC) = 1 pt; 2.0 to 3.0 mg/dL (34 to 50 µmol/L) = 2 pts; >3.0 mg/dL (>50 µmol/L) = 3 pts.

2. Serum Albumin: >3.5 g/dL (>35 g/L) = 1 pt; 2.8 to 3.5 g/dL (28 to 35 g/L) = 2 pts; <2.8 g/dL (<28 g/L) = 3 pts.

3. Coagulation Profile (INR / PT Prolongation): INR <1.7 (PT prolongation <4.0s) = 1 pt; INR 1.7 to 2.3 (PT prolongation 4.0–6.0s) = 2 pts; INR >2.3 (PT prolongation >6.0s) = 3 pts.

4. Ascites Severity: None = 1 pt; Mild or medically controlled with diuretics = 2 pts; Moderate to severe, tense, or refractory = 3 pts.

5. Hepatic Encephalopathy (West Haven): Grade 0 (None) = 1 pt; Grade 1 or 2 (mild confusion, asterixis) = 2 pts; Grade 3 or 4 (marked somnolence, coma) = 3 pts.

For a patient with a score of 15, reviewing which individual parameters contribute 2 or 3 points identifies whether the primary driver is hepatocellular synthetic failure (hypoalbuminemia, coagulopathy), biliary excretory failure (jaundice), or portal hypertension (ascites, encephalopathy). Clinicians can adjust specific laboratory values in our interactive ctp calculator above to simulate individual patient variations.

Clinical Meaning of Child-Pugh Class C

A score of 15 signifies Child-Pugh Class C (severe decompensated cirrhosis). Hepatocellular reserve is severely compromised, accompanied by profound coagulopathy, marked hypoalbuminemia, and recurrent or refractory portal hypertensive complications. Patients face high risks of spontaneous bacterial peritonitis (SBP), acute kidney injury (hepatorenal syndrome), and variceal bleeding. Immediate evaluation for liver transplantation is the definitive therapeutic pathway.

Clinicians frequently consult resources like MDCalc child pugh score to verify this classification. However, unlike automated internet tables, our clinical guidance emphasizes understanding the underlying pathophysiological mechanisms driving the score child.

Population Cohort Survival Evidence vs. Individual Life Expectancy

In historical cohorts, patients with Child-Pugh Class C demonstrated an estimated 1-year survival of approximately 45% and 2-year survival of roughly 35%. Elective non-transplant surgery carries prohibitive mortality (70%–82%) and is generally contraindicated.

Critical Ethical Mandate: In strict accordance with medical decision support ethics, our portal never outputs automated score-specific death percentages or individual expiration countdowns (e.g., "Your score is 15, therefore you have X months to live"). Natural-history cohort estimates describe untreated historical populations from decades past. In contemporary clinical hepatology, proactive medical interventions—such as curing hepatitis C with direct-acting antivirals, suppressing hepatitis B with tenofovir, achieving complete alcohol abstinence, performing endoscopic variceal ligation, administering non-selective beta-blockers (carvedilol), and placing transjugular intrahepatic portosystemic shunts (TIPS)—frequently stabilize liver function and can reduce a patient's score child over time.

Surgical Risk Stratification and MELD 3.0 Concurrence

When evaluating a patient with a Child-Pugh score of 15 for surgery, modern evidence from the VOCAL-Penn surgical risk score and Mayo Clinic models emphasizes that operative hazard depends on procedure invasiveness and urgency alongside liver reserve:

For score 15 (Class C), elective non-transplant surgery is strictly contraindicated due to prohibitive 70% to 82% operative mortality. Emergency surgery requires immediate critical care and transplant surgery co-management.

Simultaneously, clinicians must calculate MELD 3.0. While Child-Pugh provides bedside functional staging, MELD 3.0 incorporates serum creatinine, sodium, albumin, and female sex factor, serving as the official United States standard for deceased-donor liver allocation.

Drug Dosing and Pharmacokinetic Considerations for Score 15

In pharmaceutical drug labeling (FDA Section 8.6), Child-Pugh Class C designates severe hepatic impairment:

Nearly all hepatically metabolized medications lack safety data in Class C and are formally contraindicated. Severe protein binding alterations and portosystemic shunting dramatically increase toxicity risks.

Clinical takeaways

  • Score 15 = Child-Pugh Class C.
  • Severe decompensation; urgent liver transplant evaluation required.
  • Always check renal function and compute MELD 3.0 concurrently.

Limitations

  • Excludes serum creatinine and acute kidney injury metrics (captured by MELD 3.0).
  • Subjective grading of ascites and hepatic encephalopathy introduces inter-observer variance.
  • Population survival statistics must not be used as individualized survival predictions.

References

  1. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646-649.
  2. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis. J Hepatol. 2006;44(1):217-231.
  3. Kim WR, et al. MELD 3.0. Gastroenterology. 2021;161(6):1887-1895.e4.
  4. AASLD Practice Guidance on Cirrhosis. Hepatology. 2024.